IBDEI0WJ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16107,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16107,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,16107,1,3,0)
 ;;=3^ARANESP (ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,16108,0)
 ;;=J1826^^104^998^25^^^^1
 ;;^UTILITY(U,$J,358.3,16108,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16108,1,2,0)
 ;;=2^J1826
 ;;^UTILITY(U,$J,358.3,16108,1,3,0)
 ;;=3^INTERFERON BETA-1A 30mcg
 ;;^UTILITY(U,$J,358.3,16109,0)
 ;;=J9217^^104^998^31^^^^1
 ;;^UTILITY(U,$J,358.3,16109,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16109,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,16109,1,3,0)
 ;;=3^LEUPROLIDE INJ 7.5MG
 ;;^UTILITY(U,$J,358.3,16110,0)
 ;;=J9218^^104^998^29^^^^1
 ;;^UTILITY(U,$J,358.3,16110,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16110,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,16110,1,3,0)
 ;;=3^LEUPROLIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,16111,0)
 ;;=J1950^^104^998^30^^^^1
 ;;^UTILITY(U,$J,358.3,16111,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16111,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,16111,1,3,0)
 ;;=3^LEUPROLIDE INJ 3.75MG
 ;;^UTILITY(U,$J,358.3,16112,0)
 ;;=J9219^^104^998^28^^^^1
 ;;^UTILITY(U,$J,358.3,16112,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16112,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,16112,1,3,0)
 ;;=3^LEUPROLIDE IMPLANT 65MG
 ;;^UTILITY(U,$J,358.3,16113,0)
 ;;=J0696^^104^998^51^^^^1
 ;;^UTILITY(U,$J,358.3,16113,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16113,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,16113,1,3,0)
 ;;=3^ROCEPHIN INJ-250MG
 ;;^UTILITY(U,$J,358.3,16114,0)
 ;;=J0696^^104^998^50^^^^4
 ;;^UTILITY(U,$J,358.3,16114,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16114,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,16114,1,3,0)
 ;;=3^ROCEPHIN INJ-1GM
 ;;^UTILITY(U,$J,358.3,16115,0)
 ;;=J1030^^104^998^35^^^^1
 ;;^UTILITY(U,$J,358.3,16115,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16115,1,2,0)
 ;;=2^J1030
 ;;^UTILITY(U,$J,358.3,16115,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 40MG
 ;;^UTILITY(U,$J,358.3,16116,0)
 ;;=J1020^^104^998^34^^^^1
 ;;^UTILITY(U,$J,358.3,16116,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16116,1,2,0)
 ;;=2^J1020
 ;;^UTILITY(U,$J,358.3,16116,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 20MG
 ;;^UTILITY(U,$J,358.3,16117,0)
 ;;=J1040^^104^998^36^^^^1
 ;;^UTILITY(U,$J,358.3,16117,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16117,1,2,0)
 ;;=2^J1040
 ;;^UTILITY(U,$J,358.3,16117,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 80MG
 ;;^UTILITY(U,$J,358.3,16118,0)
 ;;=J2920^^104^998^38^^^^1
 ;;^UTILITY(U,$J,358.3,16118,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16118,1,2,0)
 ;;=2^J2920
 ;;^UTILITY(U,$J,358.3,16118,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 40MG
 ;;^UTILITY(U,$J,358.3,16119,0)
 ;;=J2930^^104^998^37^^^^1
 ;;^UTILITY(U,$J,358.3,16119,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16119,1,2,0)
 ;;=2^J2930
 ;;^UTILITY(U,$J,358.3,16119,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 125MG
 ;;^UTILITY(U,$J,358.3,16120,0)
 ;;=J1756^^104^998^26^^^^1
 ;;^UTILITY(U,$J,358.3,16120,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16120,1,2,0)
 ;;=2^J1756
 ;;^UTILITY(U,$J,358.3,16120,1,3,0)
 ;;=3^IRON SUCROSE INJ 1MG
 ;;^UTILITY(U,$J,358.3,16121,0)
 ;;=J1745^^104^998^22^^^^1
 ;;^UTILITY(U,$J,358.3,16121,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16121,1,2,0)
 ;;=2^J1745
 ;;^UTILITY(U,$J,358.3,16121,1,3,0)
 ;;=3^INFLIXIMAB INJ 10MG
 ;;^UTILITY(U,$J,358.3,16122,0)
 ;;=J2916^^104^998^13^^^^1
 ;;^UTILITY(U,$J,358.3,16122,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16122,1,2,0)
 ;;=2^J2916
 ;;^UTILITY(U,$J,358.3,16122,1,3,0)
 ;;=3^FERRIC GLUCOMATE 12.5MG
 ;;^UTILITY(U,$J,358.3,16123,0)
 ;;=J0129^^104^998^1^^^^1
